Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carlo Crispino"'
Autor:
Oscar, Corli, Vittorio, Iorno, Lorenzo, Legramandi, Eliana, Rulli, Anna, Roberto, Giuseppe, Azzarello, Stefania, Schiavon, Luigi, Cavanna, Stefano, De Santis, Claudio, Cartoni, Pierangelo, Di Marco, Mario, Dauri, Rosario, Mistretta, Roberto, Bortolussi, Mario, Clerico, Manuela, Pacchioni, Carlo, Crispino, Mirko, Marabese, Nicole, Corsi, Leonardo, Trentin
Publikováno v:
Pain practice : the official journal of World Institute of Pain.
Oxycodone-Naloxone (OXN) aims to reduce opioid-related constipation while being successfully analgesic.We evaluated the analgesic response, prevalence, and severity of side effects in 176 cancer patients with moderate to severe pain and treated with
Autor:
Oscar Nappi, Danilo Rocco, Nicla de Rosa, Claudio Bellevicine, Franco Vito Piantedosi, Giancarlo Troncone, Umberto Malapelle, Carlo Crispino, Alfonso Illiano
Publikováno v:
Journal of Clinical Pathology. 65:87-91
In advanced non-small-cell lung carcinomas epidermal growth factor receptor (EGFR) and KRAS testing is often performed on cytology. Liquid-based cytology (LBC), which eliminates the need for slide preparation by clinicians, may be very useful. In 42
Autor:
Cesare Gridelli, Olga Martelli, Luigi Portalone, Stefano Treggiari, Maria Rita Migliorino, Enrico Cortesi, Carlo Crispino, Fabrizio Nelli, Luigi Brancaccio, Filippo De Marinis
Publikováno v:
Cancer. 98:1707-1715
BACKGROUND The objective of the current study was to define the activity and tolerability, as well as the influence on resectability, of the combination of gemcitabine, paclitaxel, and cisplatin (GTP) as induction chemotherapy for patients with Stage
Autor:
Filippo Demarinis, Paolo Pronzato, Domenico Sambiasi, Luigi Portalone, A. Lombardi, Luigi Friggeri, Carlo Crispino, Vito Lorusso, Mauro Signora, Antonio Antilli, Francesco Nunziati
Publikováno v:
Scopus-Elsevier
Malignant pleural mesothelioma represents a rare disease, for which chemotherapy actually remains unsatisfactory. From August 1998 to November 2001, 28 chemo-radio-immunonaive patients were consecutively enrolled in the trial: 22/6 males/females; med
Autor:
R D’Aniello, L. Manzione, G P Ianniello, L. Brancaccio, S. Cigolari, C. Gridelli, Domenico Bilancia, Emiddio Barletta, P. Masullo, Tonino Pedicini, Carlo Crispino, M L Barzelloni, G. De Cataldis, A. Maiorino, M Di Lanno, Luigi Maiorino, Alessandra Rossi
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 28(3)
Purpose : to evaluate the activity and toxicity of the combination cisplatin plus vinorelbine plus amifostine in advanced non small cell lung cancer (NSCLC). Patients and methods : a two-stage Simon design was applied. To proceed after the first stag
Autor:
Olga Martelli, Filippo de Marinis, L. Brancaccio, Stefano Treggiari, Luigi Portalone, Carlo Crispino, Maria Rita Migliorino, Enrico Cortesi, Luca Paoluzzi, Fabrizio Nelli
Publikováno v:
Lung Cancer. 41:S151
Autor:
Filippo De Marinis, Fabrizio Nelli, Maria Rita Migliorino, Olga Martelli, Enrico Cortesi, Stefano Treggiari, Luigi Portalone, Carlo Crispino, Luigi Brancaccio, Cesare Gridelli
Publikováno v:
Cancer (0008543X); 10/15/2003, Vol. 98 Issue 8, p1707, 9p